FDA Upgrades Compounded GLP-1 Recall to Class II: How to Check Your Vial
In October 2026, the FDA reclassified the earlier compounded tirzepatide recall as a Class II recall, according to reporting in the Tennessean and other outlets. If you use a compounded GLP-1, it's worth understanding exactly what that classification means — because the label sounds scarier than the practical risk in this case.
What "Class II" Actually Means
The FDA uses three recall classes to describe severity:
- Class I — reasonable probability of serious harm or death.
- Class II — use may cause temporary or medically reversible harm, or the chance of serious harm is remote.
- Class III — unlikely to cause harm, usually a labeling or minor quality issue.
A Class II designation means the affected compounded tirzepatide could cause temporary or reversible health consequences, with serious harm considered remote. It's a meaningful caution — not a worst-case emergency — but it still means you should not use an affected vial.
How to Check Your Vial
- Locate the pharmacy name and lot number on your vial or packaging.
- Match them against the official FDA recall notice and any notice from your pharmacy.
- If your product matches, stop using it and contact your provider for a safe replacement plan.
- If you're unsure, call your compounding pharmacy directly and ask whether your lot is included.
Why This Keeps Happening
Compounded GLP-1s aren't individually reviewed by the FDA before sale, and the ingredient supply chain has drawn scrutiny this year. That combination makes recalls more likely in the compounded market than with brand-name pens. It's not a reason to panic — it's a reason to know your source and keep records.
The Bottom Line
A Class II recall means: check your lot, don't use anything affected, and talk to your provider about a safe alternative. Keeping a simple log of each vial's pharmacy and lot number turns a recall headline into a 30-second check instead of an anxious scramble.
This article summarizes public reporting for general information and is not medical advice. Content was rephrased for compliance. Always follow official FDA recall notices and your provider's guidance.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment protocol.